Clinical trials: Prostate Cancer Screening, open to volunteers
- Condition Prostate Cancer Screening
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Prostate Cancer Screening
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
Prostate biopsy is the definitive examination to establish the diagnosis of prostate cancer, but up to 40% of these biopsies overestimate or underestimate the severity of the disease.
- Trial name
- NCT06830265
- Testing
- Novel needle biopsy catheter (test)
- Where
- 3 sites in United States
- Volunteers
- 200 people
- Sponsor
- Uro-1 Medical
Prostate Cancer, Prostate Cancer Screening Decision
Clinical Utility of ClarityDX Prostate
ClarityDX Prostate builds upon the utility of total and free PSA as well as simple clinical features in a decision support model to determine a patient's risk of having clinically significant prostate cancer.
- Conditions
- Prostate Cancer, Prostate Cancer Screening Decision, Prostate Cancer Screening
- Trial name
- NCT06678828
- Testing
- ClarityDX Prostate, ClarityDX Prostate, blinded
- Where
- 5 sites in Canada
- Volunteers
- 1,450 people
- Sponsor
- Nanostics